NYSE - Nasdaq Real Time Price USD

Stride, Inc. (LRN)

157.47
+0.52
+(0.33%)
As of 3:22:39 PM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 613.38M
Earnings 99.35M

Q2'24

Q3'24

Q4'24

Q1'25

0
200M
400M
600M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

144.75 Low
157.75 Average
157.47 Current
170.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3233
Avg. Estimate 1.891.037.357.92
Low Estimate 1.720.936.787.3
High Estimate 1.991.137.728.41
Year Ago EPS 1.420.944.697.35

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4266
Avg. Estimate 626.23M596.1M2.37B2.58B
Low Estimate 621.8M595.3M2.34B2.5B
High Estimate 629.1M596.9M2.38B2.65B
Year Ago Sales 534.18M551.08M2.04B2.37B
Sales Growth (year/est) 17.23%8.17%16.32%8.70%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 1.310.272.032.15
EPS Actual 1.420.942.032.02
Difference 0.110.670-0.13
Surprise % 8.32%246.80%0.00%-5.90%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 1.891.037.357.92
7 Days Ago 1.781.067.217.73
30 Days Ago 1.710.946.927.43
60 Days Ago 1.710.946.927.43
90 Days Ago 1.710.946.927.43

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 3--33
Up Last 30 Days 3133
Down Last 7 Days --2----
Down Last 30 Days --1----

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
LRN 32.86%9.57%56.72%7.80%
S&P 500 13.32%2.69%7.77%13.75%

Upgrades & Downgrades

Maintains Barrington Research: Outperform to Outperform 4/30/2025
Maintains Canaccord Genuity: Buy to Buy 4/28/2025
Maintains Barrington Research: Outperform to Outperform 4/17/2025
Maintains BMO Capital: Outperform to Outperform 4/1/2025
Maintains Barrington Research: Outperform to Outperform 3/14/2025
Maintains Canaccord Genuity: Buy to Buy 3/11/2025

Related Tickers